Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Syndax Pharmaceuticals
H. Lee Moffitt Cancer Center and Research Institute
Valerio Therapeutics
Pharmacyclics LLC.
National Institutes of Health Clinical Center (CC)